EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19

OBJECTIVES: Severe systemic inflammation associated with some stages of COVID-19 and in fatal cases led therapeutic agents developed or used frequently in Rheumatology being at the vanguard of experimental therapeutics strategies. The aim of this project was to elaborate EULAR Points to consider (Pt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Rheum Dis
Main Authors: Alunno, Alessia, Najm, Aurélie, Machado, Pedro M, Bertheussen, Heidi, Burmester, Gerd R, Carubbi, Francesco, De Marco, Gabriele, Giacomelli, Roberto, Hermine, Olivier, Isaacs, John D, Koné-Paut, Isabelle, Magro-Checa, César, McInnes, Iain, Meroni, Pier Luigi, Quartuccio, Luca, Ramanan, Athimalaipet V, Ramos-Casals, Manuel, Rodríguez Carrio, Javier, Schulze-Koops, Hendrik, Stamm, Tanja A, Tas, Sander W, Terrier, Benjamin, McGonagle, Dennis G, Mariette, Xavier
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Recommendation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7871226/
https://ncbi.nlm.nih.gov/pubmed/33547062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2020-219724
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados